This page contains brief information about tepotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Tepotinib hydrochloride is approved to treat:
- Non-small cell lung cancer that has a certain mutation in the MET gene. It is used in adults whose disease has metastasized.
This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that tepotinib hydrochloride provides a clinical benefit in these patients.
Tepotinib hydrochloride is also being studied in the treatment of other types of cancer.
More About Tepotinib Hydrochloride
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Tepotinib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.